Literature DB >> 16807390

The burden of lung disease.

R Hubbard.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16807390      PMCID： PMC2104658          DOI： 10.1136/thx.2006.066050

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  9 in total

1.  Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men.

Authors:  J R Stradling; J H Crosby
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

Review 2.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 3.  COPD exacerbations. 4: Prevention.

Authors:  S Scott; P Walker; P M A Calverley
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

4.  Is screening for lung cancer using low dose spiral CT scanning worthwhile?

Authors:  F V Gleeson
Journal:  Thorax       Date:  2006-01       Impact factor: 9.139

5.  Mortality rates from cryptogenic fibrosing alveolitis in seven countries.

Authors:  R Hubbard; I Johnston; D B Coultas; J Britton
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

6.  Rising mortality from cryptogenic fibrosing alveolitis.

Authors:  I Johnston; J Britton; W Kinnear; R Logan
Journal:  BMJ       Date:  1990-11-03

7.  Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival.

Authors:  A Imperatori; R N Harrison; D N Leitch; F Rovera; G Lepore; G Dionigi; P Sutton; L Dominioni
Journal:  Thorax       Date:  2005-11-11       Impact factor: 9.139

8.  Obstructive sleep apnea as a risk factor for stroke and death.

Authors:  H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

Review 9.  Sleep. 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history.

Authors:  J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139
  9 in total
  13 in total

1.  Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism.

Authors:  Qiong-Fang Yang; Ting-Ting Lu; Cai-Min Shu; Lan-Fang Feng; Hao-Teng Chang; Qiao-Ying Ji
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

Review 2.  Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies.

Authors:  Maria B Ospina; Donald C Voaklander; Michael K Stickland; Malcolm King; Ambikaipakan Senthilselvan; Brian H Rowe
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

3.  Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.

Authors:  A A R Thompson; R S Dickinson; F Murphy; J P Thomson; H M Marriott; A Tavares; J Willson; L Williams; A Lewis; A Mirchandani; P Dos Santos Coelho; C Doherty; E Ryan; E Watts; N M Morton; S Forbes; R H Stimson; A G Hameed; N Arnold; J A Preston; A Lawrie; V Finisguerra; M Mazzone; P Sadiku; J Goveia; F Taverna; P Carmeliet; S J Foster; E R Chilvers; A S Cowburn; D H Dockrell; R S Johnson; R R Meehan; M K B Whyte; S R Walmsley
Journal:  Sci Immunol       Date:  2017-02-10

4.  The pattern of respiratory disease morbidity and mortality in a tertiary hospital in southern-eastern Nigeria.

Authors:  Victor Aniedi Umoh; Akaninyene Otu; Henry Okpa; Emmanuel Effa
Journal:  Pulm Med       Date:  2013-12-17

5.  The role of iron in pulmonary pathology.

Authors:  Heena Khiroya; Alice M Turner
Journal:  Multidiscip Respir Med       Date:  2015-12-01

6.  Home monitoring of breathing rate in people with chronic obstructive pulmonary disease: observational study of feasibility, acceptability, and change after exacerbation.

Authors:  Noah Rubio; Richard A Parker; Ellen M Drost; Hilary Pinnock; Christopher J Weir; Janet Hanley; Leandro C Mantoani; William MacNee; Brian McKinstry; Roberto A Rabinovich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-20

7.  Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling.

Authors:  Dan C Wilkinson; Jackelyn A Alva-Ornelas; Jennifer M S Sucre; Preethi Vijayaraj; Abdo Durra; Wade Richardson; Steven J Jonas; Manash K Paul; Saravanan Karumbayaram; Bruce Dunn; Brigitte N Gomperts
Journal:  Stem Cells Transl Med       Date:  2016-09-15       Impact factor: 6.940

8.  The Effects of Safflower Yellow on Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Clinical Trial.

Authors:  Xiao-Jin Li; Yan Kang; Ru-Rong Wang; Xue-Lian Liao; Xiao-Feng Ou; Jin Liu; Yun-Xia Zuo
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-08       Impact factor: 2.629

Review 9.  Application of iPSC to Modelling of Respiratory Diseases.

Authors:  Ben A Calvert; Amy L Ryan Firth
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 10.  Long-term differentiating primary human airway epithelial cell cultures: how far are we?

Authors:  Zuzanna Bukowy-Bieryłło
Journal:  Cell Commun Signal       Date:  2021-05-27       Impact factor: 5.712
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.